<DOC>
	<DOCNO>NCT00347750</DOCNO>
	<brief_summary>The objective proposal base assumption HIV infect Ethiopian population respond different way comparison Caucasian subject Lopinavir therapy . Our preliminary data demonstrate Ethiopian 's different Lopinavir serum concentration comparison non-Ethiopian 's . For reason plan study investigate pharmacokinetic/pharmacodynamic ( PK/PD ) profile population . The result allow establish good personalised medicine HIV infect individual .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Anti-HIV Drug Israeli Ethiopian Non-Ethiopian Populations</brief_title>
	<detailed_description>The objective proposal base assumption HIV infect Ethiopian population respond different way comparison Caucasian subject Lopinavir therapy . Our preliminary data demonstrate Ethiopian 's different Lopinavir serum concentration comparison non-Ethiopian 's . For reason plan study investigate pharmacokinetic/pharmacodynamic ( PK/PD ) profile population . The result allow establish good personalised medicine HIV infect individual .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Anti-HIV Agents</mesh_term>
	<criteria>All HIV infect Ethiopian NonEthiopian subject AIDS diseased Ethiopian NonEthiopian individual Individuals unable sign inform concent Individuals unable take oral medication Individuals describe Lopinavir allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Lopinavir</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Ethiopian population</keyword>
	<keyword>Caucasian population</keyword>
</DOC>